Connect with us


Medipharm Labs Corporation (OTCMKTS:MEDIF) Expands Its Innovative Branded Products Line With Launch Of New Formulations



Medipharm Labs Corporation (OTCMKTS:MEDIF) has announced the expansion of its innovative Pharma-quality family branded products with the launch of THC 30, CBD 100, and its first cannabinoid cannabinol (CBN) rich formula.

MediPharm creating CBD products for wellness and medical needs

Keith Strachan, the company’s interim CEO, said that MediPharm is dedicated to creating customized innovative products that customers can trust for wellness and medicinal needs. Strachan said that the release of new CBD formulas, including the first minor cannabinoid CBN formulation, enables the company to fill the growing consumer need for more customized products while maintaining the commitment to pharma-quality production.

These new products are MediPharm’s latest in its branded products family, and each delivers a unique flavor profile from the naturally occurring cannabis terpenes. Each uses palm/coconut-based MCT carrier oil carefully picked for sustainable practices, and each produced as per the company’s manufacturing standards to maintain the highest quality and purity. The products include THC30 formula oil, which contains 30mg/ml, and CBD100 Ultra formula oil, which contains the highest CBD available at 100g/ml.

Similarly, MediPharm Labs launched next-generation oil products with the first CBN formula. CBN1:2 Nighttime Formula contains 10mg/ml of CBN and 20mg/ml of THC, and it employs full-spectrum cannabis concentrate CBN.

CBN available in traces in cannabis but can be oxidized

CBN is usually available in cannabis plants in trace quantities but can be produced through THC oxidation. It binds to endocannabinoid CB1 receptors just like THC, but its binding is 8-10 times less strong, leading to less psychoactive effects than the same THC dose.

Patients can access initial quantities in the coming weeks through Medical Cannabis by Shoppers™. However, consumers can access through retail channels in Alberta, Manitoba, British Columbia, Saskatchewan, and Ontario. The company expects to attain full national distribution of the full suite of cannabis products to be a “One-Stop-Shop” for distributors and retailers across the country. The company is known to process, package, test, and distribute cannabis concentrates and advanced CBD-based products for the Canadian by leveraging its white label and wholesale platforms.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.